M&T Bank
ELAN icon

M&T Bank’s Elanco Animal Health ELAN Stock Holding History

M&T Bank’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$558K Sell
22,636
-3,670
-14% -$84.9K ﹤0.01% 1152
2026
Q1 		$630K Buy
26,306
+1,816
+7% +$44.4K ﹤0.01% 1026
2025
Q4 		$554K Buy
24,490
+5,032
+26% +$110K ﹤0.01% 1073
2025
Q3 		$392K Sell
19,458
-5,571
-22% -$93.3K ﹤0.01% 1081
2025
Q2 		$358K Buy
25,029
+971
+4% +$11.3K ﹤0.01% 1200
2025
Q1 		$253K Sell
24,058
-1,445
-6% -$16.3K ﹤0.01% 1322
2024
Q4 		$309K Sell
25,503
-904
-3% -$11.8K ﹤0.01% 1370
2024
Q3 		$388K Buy
26,407
+1,464
+6% +$20.4K ﹤0.01% 1257
2024
Q2 		$360K Buy
24,943
+2,620
+12% +$41.9K ﹤0.01% 1232
2024
Q1 		$364K Sell
22,323
-34
-0.2% -$532 ﹤0.01% 1252
2023
Q4 		$334K Sell
22,357
-7,755
-26% -$87.8K ﹤0.01% 1278
2023
Q3 		$339K Buy
30,112
+1,059
+4% +$12.3K ﹤0.01% 1229
2023
Q2 		$293K Buy
29,053
+3,833
+15% +$35.6K ﹤0.01% 1311
2023
Q1 		$237K Buy
25,220
+7,396
+41% +$87.2K ﹤0.01% 1397
2022
Q4 		$218K Sell
17,824
-216,732
-92% -$2.7M ﹤0.01% 1438
2022
Q3 		$2.91M Buy
234,556
+1,819
+0.8% +$31.8K 0.01% 493
2022
Q2 		$4.57M Sell
232,737
-37,391
-14% -$885K 0.02% 384
2022
Q1 		$7.05M Buy
270,128
+27,495
+11% +$732K 0.03% 313
2021
Q4 		$6.89M Buy
242,633
+23,214
+11% +$722K 0.03% 326
2021
Q3 		$7M Buy
219,419
+18,690
+9% +$627K 0.03% 325
2021
Q2 		$6.96M Buy
200,729
+12,433
+7% +$410K 0.03% 322
2021
Q1 		$5.55M Buy
188,296
+19,069
+11% +$586K 0.02% 355
2020
Q4 		$5.19M Buy
169,227
+26,176
+18% +$799K 0.02% 364
2020
Q3 		$4M Buy
143,051
+26,438
+23% +$670K 0.02% 382
2020
Q2 		$2.5M Buy
116,613
+101,930
+694% +$2.25M 0.01% 466
2020
Q1 		$329K Buy
14,683
+5,263
+56% +$144K ﹤0.01% 1069
2019
Q4 		$277K Buy
9,420
+9
+0.1% +$245 ﹤0.01% 1122
2019
Q3 		$251K Sell
9,411
-3,414
-27% -$102K ﹤0.01% 1306
2019
Q2 		$433K Buy
+12,825
New +$416K ﹤0.01% 1045

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

M&T Bank's ELAN Position: Q2 2026 in Review

M&T Bank reduced its Elanco Animal Health (ELAN) stake by 14% in Q2 2026, selling an estimated $84.9K and leaving 22,636 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #1152.

M&T Bank first reported a position in ELAN in Q2 2019 and has held it in 29 quarters since. The position peaked at $7.05M in Q1 2022. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • M&T Bank held 22,636 shares of Elanco Animal Health worth $558K as of Q2 2026.
  • M&T Bank sold 3,670 Elanco Animal Health shares in Q2 2026, an estimated $84.9K.
  • Elanco Animal Health made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1152 holding.
  • M&T Bank first reported a position in Elanco Animal Health in Q2 2019 and has held it in 29 quarters since.
  • M&T Bank's Elanco Animal Health position peaked at $7.05M in Q1 2022.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.